Trial pipeline · NCT07300813
Olistic_2025 for Hair Loss, Hair Growth, and Skin Improvement
Not applicable Active, not recruiting status last verified 2025-12
A registered clinical trial, reproduced from its ClinicalTrials.gov record. Every value on this page is a field on that record. Nothing on this page is a finding, an assessment or a recommendation.
The registered record
- Accession number
- NCT07300813
- Lead sponsor
- Bionos Biotech S.L. (industry)
- Registered conditions naming hair loss
- Hair LossFemale Pattern Hair Loss
- Also registered on this record
- Hair Care
- Official title
- Clinical Evaluation of Hair Loss, Hair Growth, and Skin Improvement in Human Volunteers Following a Double-blind, Placebo-controlled, 1:1 Randomized Trial of 'Olistic Next Women'
The first row holds the registered conditions that placed this trial on the pipeline; the second holds everything else the sponsor registered on the same record. Both are shown, and shown apart rather than shaded differently, because leaving the second out would make this trial look more like a hair-loss study than its registration says it is — and because a distinction carried only by colour is not a distinction for every reader.
Interventions
- OtherOlistic Next Women
- OtherPlacebo
Names and types as registered. The sponsors' free-text descriptions of these interventions are not reproduced: they are written by the party with an interest in the result, and reprinting them inside this site's layout would lend them this site's voice.
Design
- Study type
- interventional
- Phase
- Not applicable
- Allocation
- randomized
- Masking
- quadruple
- Primary purpose
- supportive care
- Enrolment
- 100 participants (actual)
- Sites
- 1 location in Spain
What it measures
Change from baseline in hair density (hair count per cm²) measured by HairMetrix®.
Time frame: Baseline ( 2 days after clipping) 3 months (2 days after clipping), 6 months (2 days after clipping).
Primary outcome measures only, as registered. What a trial chose to measure, and when, is the most informative thing about it that is knowable before it reports — a hair-count endpoint at 24 weeks and a patient-satisfaction endpoint at 12 weeks are not the same study.
Who can take part
- Sex
- female
- Age
- 50 Years to 65 Years
- Healthy volunteers
- accepted
A summary of three registered fields, not the eligibility criteria. The full inclusion and exclusion criteria, the recruiting sites and the study contacts are on the registry record, which is the only place they are maintained. This site has no relationship with this trial and cannot refer anyone to it.
Registered dates
- Study start
- 20 October 2025 (actual)
- Primary completion
- 4 May 2026 (estimated)
- Study completion
- 1 June 2026 (estimated)
- First posted
- 24 December 2025 (actual)
- Last update posted
- 24 December 2025 (actual)
"Estimated" and "actual" are the registry's own labels: an estimated date is a plan, and plans move. A date is printed at the precision it was registered at: this record registers a primary completion to the day, so a day is what is shown. Where a sponsor registers only a month, only a month is shown.
Results
This trial has not reported results. ClinicalTrials.gov holds no results record for it. That is the ordinary state of a trial that is running or about to run, and it means there is nothing here to tell you about whether the intervention works — including nothing negative. If this page implied otherwise it would be wrong.
On this site
Guides covering the condition this trial is registered for. They are about published evidence; this page is about a registration, and the two do not overlap.
Diffuse Thinning vs. Pattern Baldness: How to Tell the Difference (2026 Guide)How to Tell If You're Going Bald: Early Signs & Self-Assessment Guide (2026)Androgenetic Alopecia: Complete GuideNew Hair Loss Treatments in Clinical Trials: Clascoterone, Pyrilutamide and What the Published Data Actually ShowComplete Guide to Finasteride for Hair LossMinoxidil 5% Complete Guide: How to Apply for Best ResultsFemale Pattern Hair Loss: Treatment Options That WorkWomen's Hair Loss: The Complete GuideSpironolactone for Hair Loss in Women
Where this came from
Read from the ClinicalTrials.gov API on 6 September 2026 and rebuilt into this page without alteration. ClinicalTrials.gov is a service of the U.S. National Library of Medicine and is the authority on this record; where this page and the registry disagree, the registry is right. This page is not affiliated with or endorsed by NLM or NIH, or with the sponsor of this trial.
Open NCT07300813 on ClinicalTrials.gov · All 157 trials in the pipeline